Incyte Corporation (INCY)
NASDAQ·Healthcare·Biotechnology
$118.27
-3.85%
Mkt Cap $23.69B
Analyst Ratings
Buy
20
Hold
8
Sell
0
Price Target (72 analysts)
$130.07
Range $104.00 – $155.00
Implied Upside
+10.0%
Consensus $130.07 vs current $118.27
NASDAQ·Healthcare·Biotechnology
$118.27
-3.85%
Mkt Cap $23.69B
Buy
20
Hold
8
Sell
0
Price Target (72 analysts)
$130.07
Range $104.00 – $155.00
+10.0%
Consensus $130.07 vs current $118.27